CN101708201B - 一种治疗胃溃疡的药物 - Google Patents
一种治疗胃溃疡的药物 Download PDFInfo
- Publication number
- CN101708201B CN101708201B CN2009102420209A CN200910242020A CN101708201B CN 101708201 B CN101708201 B CN 101708201B CN 2009102420209 A CN2009102420209 A CN 2009102420209A CN 200910242020 A CN200910242020 A CN 200910242020A CN 101708201 B CN101708201 B CN 101708201B
- Authority
- CN
- China
- Prior art keywords
- loropetalum
- chinens
- extract
- crude extract
- gastric ulcer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000003814 drug Substances 0.000 title claims abstract description 21
- 208000007107 Stomach Ulcer Diseases 0.000 title claims abstract description 20
- 201000005917 gastric ulcer Diseases 0.000 title claims abstract description 20
- 241000906054 Loropetalum Species 0.000 claims abstract description 57
- 239000000287 crude extract Substances 0.000 claims abstract description 36
- 238000000034 method Methods 0.000 claims description 34
- 239000000284 extract Substances 0.000 claims description 26
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- 238000000605 extraction Methods 0.000 claims description 8
- 239000000463 material Substances 0.000 claims description 8
- 238000002360 preparation method Methods 0.000 claims description 8
- 241000894006 Bacteria Species 0.000 claims description 7
- 230000002879 macerating effect Effects 0.000 claims description 7
- 239000002994 raw material Substances 0.000 claims description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 3
- 150000001720 carbohydrates Chemical class 0.000 claims description 3
- 229930002875 chlorophyll Natural products 0.000 claims description 3
- 235000019804 chlorophyll Nutrition 0.000 claims description 3
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 claims description 3
- 239000000469 ethanolic extract Substances 0.000 claims description 3
- 239000012535 impurity Substances 0.000 claims description 3
- 238000001556 precipitation Methods 0.000 claims description 3
- 238000007560 sedimentation technique Methods 0.000 claims description 3
- 108090000790 Enzymes Proteins 0.000 claims description 2
- 102000004190 Enzymes Human genes 0.000 claims description 2
- 239000002023 wood Substances 0.000 claims description 2
- 238000002474 experimental method Methods 0.000 abstract description 13
- 208000010110 spontaneous platelet aggregation Diseases 0.000 abstract description 13
- 241001465754 Metazoa Species 0.000 abstract description 9
- 238000000338 in vitro Methods 0.000 abstract description 6
- 241000906048 Loropetalum chinense Species 0.000 description 25
- 241000700159 Rattus Species 0.000 description 12
- 108090000190 Thrombin Proteins 0.000 description 12
- 230000000694 effects Effects 0.000 description 12
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 12
- 229960004072 thrombin Drugs 0.000 description 12
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 10
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 10
- 238000012360 testing method Methods 0.000 description 10
- IYRMWMYZSQPJKC-UHFFFAOYSA-N kaempferol Chemical compound C1=CC(O)=CC=C1C1=C(O)C(=O)C2=C(O)C=C(O)C=C2O1 IYRMWMYZSQPJKC-UHFFFAOYSA-N 0.000 description 9
- 230000004520 agglutination Effects 0.000 description 8
- 241000699670 Mus sp. Species 0.000 description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 230000037396 body weight Effects 0.000 description 6
- 230000002496 gastric effect Effects 0.000 description 6
- 238000001802 infusion Methods 0.000 description 6
- 150000002500 ions Chemical class 0.000 description 6
- 239000000843 powder Substances 0.000 description 6
- 210000002784 stomach Anatomy 0.000 description 6
- UBSCDKPKWHYZNX-UHFFFAOYSA-N Demethoxycapillarisin Natural products C1=CC(O)=CC=C1OC1=CC(=O)C2=C(O)C=C(O)C=C2O1 UBSCDKPKWHYZNX-UHFFFAOYSA-N 0.000 description 5
- 239000012153 distilled water Substances 0.000 description 5
- 235000008777 kaempferol Nutrition 0.000 description 5
- LRDGATPGVJTWLJ-UHFFFAOYSA-N luteolin Natural products OC1=CC(O)=CC(C=2OC3=CC(O)=CC(O)=C3C(=O)C=2)=C1 LRDGATPGVJTWLJ-UHFFFAOYSA-N 0.000 description 5
- 235000009498 luteolin Nutrition 0.000 description 5
- UXOUKMQIEVGVLY-UHFFFAOYSA-N morin Natural products OC1=CC(O)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 UXOUKMQIEVGVLY-UHFFFAOYSA-N 0.000 description 5
- 210000004623 platelet-rich plasma Anatomy 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 4
- 229960000583 acetic acid Drugs 0.000 description 4
- IQPNAANSBPBGFQ-UHFFFAOYSA-N luteolin Chemical compound C=1C(O)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(O)C(O)=C1 IQPNAANSBPBGFQ-UHFFFAOYSA-N 0.000 description 4
- 238000012856 packing Methods 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- -1 Dichlorodiphenyl Acetates Chemical class 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- 208000025865 Ulcer Diseases 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 239000000470 constituent Substances 0.000 description 3
- 238000007405 data analysis Methods 0.000 description 3
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical group OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 231100000397 ulcer Toxicity 0.000 description 3
- KJXSIXMJHKAJOD-LSDHHAIUSA-N (+)-dihydromyricetin Chemical compound C1([C@@H]2[C@H](C(C3=C(O)C=C(O)C=C3O2)=O)O)=CC(O)=C(O)C(O)=C1 KJXSIXMJHKAJOD-LSDHHAIUSA-N 0.000 description 2
- AAWZDTNXLSGCEK-LNVDRNJUSA-N (3r,5r)-1,3,4,5-tetrahydroxycyclohexane-1-carboxylic acid Chemical compound O[C@@H]1CC(O)(C(O)=O)C[C@@H](O)C1O AAWZDTNXLSGCEK-LNVDRNJUSA-N 0.000 description 2
- 206010002091 Anaesthesia Diseases 0.000 description 2
- AAWZDTNXLSGCEK-UHFFFAOYSA-N Cordycepinsaeure Natural products OC1CC(O)(C(O)=O)CC(O)C1O AAWZDTNXLSGCEK-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 241000287828 Gallus gallus Species 0.000 description 2
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- IQPSEEYGBUAQFF-UHFFFAOYSA-N Pantoprazole Chemical compound COC1=CC=NC(CS(=O)C=2NC3=CC=C(OC(F)F)C=C3N=2)=C1OC IQPSEEYGBUAQFF-UHFFFAOYSA-N 0.000 description 2
- QGMRQYFBGABWDR-UHFFFAOYSA-M Pentobarbital sodium Chemical compound [Na+].CCCC(C)C1(CC)C(=O)NC(=O)[N-]C1=O QGMRQYFBGABWDR-UHFFFAOYSA-M 0.000 description 2
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 2
- AAWZDTNXLSGCEK-ZHQZDSKASA-N Quinic acid Natural products O[C@H]1CC(O)(C(O)=O)C[C@H](O)C1O AAWZDTNXLSGCEK-ZHQZDSKASA-N 0.000 description 2
- 241000700157 Rattus norvegicus Species 0.000 description 2
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 230000037005 anaesthesia Effects 0.000 description 2
- 230000000680 avirulence Effects 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000009849 deactivation Effects 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 229930003935 flavonoid Natural products 0.000 description 2
- 150000002215 flavonoids Chemical class 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- 238000007710 freezing Methods 0.000 description 2
- 230000008014 freezing Effects 0.000 description 2
- 239000012362 glacial acetic acid Substances 0.000 description 2
- 238000000703 high-speed centrifugation Methods 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 229960005019 pantoprazole Drugs 0.000 description 2
- 229960002275 pentobarbital sodium Drugs 0.000 description 2
- 230000003285 pharmacodynamic effect Effects 0.000 description 2
- 210000002381 plasma Anatomy 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 235000005875 quercetin Nutrition 0.000 description 2
- 229960001285 quercetin Drugs 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000005070 sampling Methods 0.000 description 2
- 239000001509 sodium citrate Substances 0.000 description 2
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 2
- 238000001694 spray drying Methods 0.000 description 2
- 238000000825 ultraviolet detection Methods 0.000 description 2
- 238000003809 water extraction Methods 0.000 description 2
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 1
- FRXSZNDVFUDTIR-UHFFFAOYSA-N 6-methoxy-1,2,3,4-tetrahydroquinoline Chemical compound N1CCCC2=CC(OC)=CC=C21 FRXSZNDVFUDTIR-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 1
- 241000272201 Columbiformes Species 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 1
- 101710146739 Enterotoxin Proteins 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- NRSUOHVIKLCXEE-UHFFFAOYSA-N Isorhamnetin 3-O-beta-D-glucopyranoside Natural products CCC1OC(OC2=C(Oc3cc(O)cc(O)c3C2=O)c4ccc(O)c(OC)c4)C(O)C(O)C1O NRSUOHVIKLCXEE-UHFFFAOYSA-N 0.000 description 1
- 238000012449 Kunming mouse Methods 0.000 description 1
- SHZGCJCMOBCMKK-JFNONXLTSA-N L-rhamnopyranose Chemical compound C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O SHZGCJCMOBCMKK-JFNONXLTSA-N 0.000 description 1
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 1
- 238000011887 Necropsy Methods 0.000 description 1
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 1
- 208000005374 Poisoning Diseases 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 125000003158 alcohol group Chemical group 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 230000002547 anomalous effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 1
- 229940074393 chlorogenic acid Drugs 0.000 description 1
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 1
- 235000001368 chlorogenic acid Nutrition 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- KQILIWXGGKGKNX-UHFFFAOYSA-N dihydromyricetin Natural products OC1C(=C(Oc2cc(O)cc(O)c12)c3cc(O)c(O)c(O)c3)O KQILIWXGGKGKNX-UHFFFAOYSA-N 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 239000000147 enterotoxin Substances 0.000 description 1
- 231100000655 enterotoxin Toxicity 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 238000007667 floating Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- HQVFCQRVQFYGRJ-UHFFFAOYSA-N formic acid;hydrate Chemical compound O.OC=O HQVFCQRVQFYGRJ-UHFFFAOYSA-N 0.000 description 1
- 235000004515 gallic acid Nutrition 0.000 description 1
- 229940074391 gallic acid Drugs 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000037308 hair color Effects 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000002439 hemostatic effect Effects 0.000 description 1
- 230000008676 import Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 231100000566 intoxication Toxicity 0.000 description 1
- 230000035987 intoxication Effects 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- CQLRUIIRRZYHHS-LFXZADKFSA-N isorhamnetin 3-O-beta-D-glucopyranoside Chemical compound C1=C(O)C(OC)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)=C1 CQLRUIIRRZYHHS-LFXZADKFSA-N 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 238000001819 mass spectrum Methods 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000006199 nebulizer Substances 0.000 description 1
- 235000021590 normal diet Nutrition 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 229960004048 pantoprazole sodium Drugs 0.000 description 1
- YNWDKZIIWCEDEE-UHFFFAOYSA-N pantoprazole sodium Chemical compound [Na+].COC1=CC=NC(CS(=O)C=2[N-]C3=CC=C(OC(F)F)C=C3N=2)=C1OC YNWDKZIIWCEDEE-UHFFFAOYSA-N 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 238000005325 percolation Methods 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000024053 secondary metabolic process Effects 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000001256 steam distillation Methods 0.000 description 1
- 238000000194 supercritical-fluid extraction Methods 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 238000002137 ultrasound extraction Methods 0.000 description 1
- 230000003639 vasoconstrictive effect Effects 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Images
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
tR(min) | [M-H]-(m/z) | Product ion | 分子式 | 化合物名称 |
13.97 | 353.2 | 191.0,179.0,173.0 | C16H18O9 | 绿原酸 |
16.44 | 337.2 | 191.2 | C13H22O10 | 奎尼酸+鼠李糖 |
17.42 | 415.2 | C21H20O9 | 芹菜素-O-葡萄糖苷 | |
18.49 | 477.1 | 313.2 | C22H22O12 | 异鼠李素-3-O-葡萄糖苷 |
19.50 | 479.3 | 316.0 | C21H20O13 | 杨梅素-3-O-葡萄糖苷 |
20.69 | 463.2 | 316.1 | C21H20O12 | 杨梅素-3-O-鼠李糖苷 |
21.36 | 463.2 | 301.0 | C21H20O12 | 槲皮素-7(3)-O-葡萄糖苷 |
22.12 | 599.2 | 447.1,313.2 | C28H24O15 | 黄芪苷-2(6)-O-没食子酸酯 |
22.83 | 447.2 | 285.1 | C21H20O11 | 山奈酚(木犀草素)-3(7)-O-葡萄糖苷 |
23.14 | 447.2 | 301.1 | C21H20O11 | 槲皮素-O-鼠李糖苷 |
25.07 | 431.2 | 285.1 | C27H30O15 | 山奈酚(木犀草素)-O-鼠李糖苷 |
25.95 | 301.2 | C15H10O7 | 槲皮素 | |
26.38 | 593.0 | 285.1 | C27H30O15C30H26O13 | 木犀草素(山奈酚)-7-O-芸香糖苷山奈酚-3-(6”-对羟基桂皮酰)-葡萄糖苷 |
28.42 | 285.1 | C15H10O6 | 山奈酚(木犀草素) |
组别 | n | 浓度 | 最大聚集率(%) |
生理盐水 | 3 | - | 25.45±8.43* |
白檵木粗提物 | 3 | 500μg/mL | 8.23±9.71* |
凝血酶 | 3 | 6.4U/mL | 86.93±12.64 |
组别 | n | 浓度(μg/mL) | 最大聚集率(%) |
生理盐水+凝血酶 | 3 | - | 65.94±6.6 |
白檵木粗提物+凝血酶 | 3 | 500 | 66.26±4.4 |
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2009102420209A CN101708201B (zh) | 2009-12-02 | 2009-12-02 | 一种治疗胃溃疡的药物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2009102420209A CN101708201B (zh) | 2009-12-02 | 2009-12-02 | 一种治疗胃溃疡的药物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101708201A CN101708201A (zh) | 2010-05-19 |
CN101708201B true CN101708201B (zh) | 2012-04-04 |
Family
ID=42401022
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2009102420209A Active CN101708201B (zh) | 2009-12-02 | 2009-12-02 | 一种治疗胃溃疡的药物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101708201B (zh) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102579524A (zh) * | 2012-03-28 | 2012-07-18 | 江西徳宇集团 | 白花檵木提取物在制备愈伤药物中的应用 |
CN107913293A (zh) * | 2016-10-10 | 2018-04-17 | 刘浩元 | 一种对愈伤有效的中药组合物 |
CN108294308A (zh) * | 2018-01-17 | 2018-07-20 | 上海茂久中医药科技有限公司 | 一种白花檵木保健品及其制备方法 |
CN109157612A (zh) * | 2018-10-22 | 2019-01-08 | 刘韻赟 | 一种檵木散颗粒冲剂药物组合物及其制备方法和应用 |
-
2009
- 2009-12-02 CN CN2009102420209A patent/CN101708201B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN101708201A (zh) | 2010-05-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101062077B (zh) | 一种同时制备甜叶菊总甜菊苷和甜叶菊总黄酮的方法 | |
CN104825463B (zh) | 白肉灵芝提取物的代谢调节及抗缺氧的用途 | |
CN103054907B (zh) | 一种蜂胶总黄酮提取物及其制备方法 | |
CN101863871B (zh) | 蔷薇红景天总苷及其医药用途和制备方法 | |
Mrkonjić et al. | Optimization of antioxidants recovery from wild thyme (Thymus serpyllum L.) by ultrasound-assisted extraction: Multi-response approach | |
CN101708201B (zh) | 一种治疗胃溃疡的药物 | |
CN104042958A (zh) | 玉米须活性组分的半仿生提取方法及其抗氧化作用 | |
CN104897806B (zh) | 判断菊花是否经过硫熏的hplc检测方法 | |
CN101829224B (zh) | 一种中药组合物制剂及制备方法和检测方法 | |
CN103012356A (zh) | 一种具有α-糖苷酶抑制活性的化合物及其制备方法和用途 | |
CN101507817B (zh) | 一种高安全性注射用聚山梨酯80及其制备方法 | |
CN102000127B (zh) | 蜡梅属植物抑制乙酰胆碱酯酶活性部位的制备及其应用 | |
CN103788038A (zh) | 赤芝内酯类化合物及其药物组合物和其制备方法与应用 | |
CN101708202B (zh) | 一种抑制血管舒张的药物 | |
Meyre-Silva et al. | Phytochemical and pharmacological analysis of Bauhinia microstachya (Raddi) Macbr.(Leguminosae) | |
Kyslychenko | Flavonoids determination in the aboveground part of Achillea millefolium | |
CN109709249A (zh) | 一种基于玄参多活性成分检测的综合质量评价方法 | |
CN101084985B (zh) | 甘草高效抗菌、抗氧化活性部位的分离及鉴定 | |
CN103054038A (zh) | 一种具有降血糖活性竹叶黄酮提取物的制备方法 | |
CN103800389B (zh) | 一种Sarcodon leucopus中降糖活性成分及其制备方法与应用 | |
CN102579527A (zh) | 一种广枣叶总黄酮及其提取方法和用途 | |
Luliana et al. | Total flavonoid contents and in silico study of flavonoid compounds from Meniran (Phyllanthus niruri L.) towards alpha-amylase and alpha-glucosidase enzyme | |
CN102988342B (zh) | 环淫羊藿素苷元在制备抗炎、抗菌药物中的应用 | |
CN108129437B (zh) | 一种黄酮化合物及其制备方法与应用 | |
CN103751224B (zh) | 从蛹虫草中提取抗肿瘤活性组分的方法及其应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: LIU HAOYUAN Free format text: FORMER OWNER: DEYU GROUP CORP. JIANGXI PROV. Effective date: 20110930 Owner name: LI XIAOBIN QU SHUJUAN |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20110930 Address after: 333000 No. 11 porcelain Avenue, Jiangxi, Jingdezhen Applicant after: Liu Haoyuan Co-applicant after: Li Xiaobin Co-applicant after: Qu Shujuan Address before: 333000 No. 11 porcelain Avenue, Jiangxi, Jingdezhen Applicant before: Deyu Group Corp. Jiangxi Prov. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20100519 Assignee: Deyu Group Corp. Jiangxi Prov. Assignor: Liu Haoyuan|Li Xiaobin|Qu Shujuan Contract record no.: 2013360000164 Denomination of invention: Xiangbei notoginseng powder for treating gastric ulcer Granted publication date: 20120404 License type: Common License Record date: 20131223 |
|
LICC | Enforcement, change and cancellation of record of contracts on the licence for exploitation of a patent or utility model | ||
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20160415 Address after: 333000 No. 11 porcelain Avenue, Jiangxi, Jingdezhen Patentee after: Deyu Group Corp. Jiangxi Prov. Address before: 333000 No. 11 porcelain Avenue, Jiangxi, Jingdezhen Patentee before: Liu Haoyuan Patentee before: Li Xiaobin Patentee before: Qu Shujuan |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20190415 Address after: 333000 No. 11 Porcelain Capital Avenue, Jingdezhen City, Jiangxi Province Patentee after: Jingdezhen City, animal husbandry and Fishery Science Research Institute Address before: 333000 No. 11 Porcelain Capital Avenue, Jingdezhen City, Jiangxi Province Patentee before: Deyu Group Corp. Jiangxi Prov. |